uridine diphosphate galactose has been researched along with Experimental Mammary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, T; Handa, S; Hara, T; Kawakita, M; Kobata, A; Ogura, K; Rokukawa, C; Taki, T | 1 |
1 other study(ies) available for uridine diphosphate galactose and Experimental Mammary Neoplasms
Article | Year |
---|---|
Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity.
Topics: Animals; Antigens, CD; Cell Aggregation; Cell Division; Chromatography, Thin Layer; Female; Glycolipids; Glycosphingolipids; Killer Cells, Natural; Lactosylceramides; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mutation; Neoplasm Transplantation; Newcastle disease virus; Tumor Cells, Cultured; Uridine Diphosphate Galactose | 1991 |